-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
| New urine test technology helps improve the efficiency of prostate cancer detection |
Xinhua News Agency, London, April 27 (Reporter Zhang Jiawei) The University of East Anglia in the United Kingdom released a study on the 27th, saying that an experimental urine test developed by its researchers has the potential to improve the efficiency of prostate cancer detection and make doctors understand more quickly The extent of the disease and whether in-depth testing is required to reduce the risk of patients being overdiagnosed and overtreated.
Prostate cancer usually develops slowly, and the detection techniques currently used include blood tests, MRI scans, and prostate biopsy.
The urinalysis technology developed by researchers at the school comprehensively evaluates the expression levels of a protein marker called EN2 and 10 genes related to prostate cancer risk.
The results show that the new detection technology can successfully analyze which patient has prostate cancer, and can form relevant risk indicators for each patient, so as to tell the doctors which of them need further prostate biopsy to avoid The patient is overdiagnosed and overtreated.
Darn Brewer, a researcher at the University of East Anglia who led the study, said that invasive prostate biopsy will impose a greater burden on patients in economic and psychological aspects, and will also bring higher costs to the medical system.
The results of this research have been published in the latest issue of the British journal Cancer.
